|
|
|
Clinical Research Detail |
|
|
|
Title Of Study |
Research study to demonstrate that Intravenous iron isomaltoside is non-inferior to Oral iron sulphate in reducing iron deficiency in non-myeloid malignancies subjects associated with chemotherapy induced anaemia ,evaluated as ability to increase Haemoglobin (Hb).
|
|
|
Disease Condition |
Iron Deficiency Anemia in CIA patients Phase III, prospective, open-label, randomized comparative study
|
|
|
Phase of Trial |
Phase-3
|
Discipline |
Oncology
|
|
|
Start date of Trial |
10/20/2010
|
Closing Date of Trial |
4/20/2012
|
|
|
|